International Journal of Clinical Research

Objective To explore the clinical effect of modified Huatan Tongluo Formula in patients with acute cerebral infarction and phlegm stasis obstruction syndrome. Methods 86 patients with acute cerebral infarction and phlegm stasis obstruction syndrome admitted to our hospital from January 2023 to January 2024 were randomly divided into a control group (conventional treatment) and an observation group (modified Huatan Tongluo Formula treatment), with 43 patients in each group. The clinical efficacy of the two groups was compared. Results There was no statistically significant difference in the scores of traditional Chinese medicine syndrome and neurological function between the two groups before treatment (P>0.05). After treatment, the traditional Chinese medicine symptom score and neurological function score in the observation group were lower than those in the control group, and the differences were statistically significant (P<0.05). Conclusion In clinical practice, the modified Huatan Tongluo Formula can significantly reduce traditional Chinese medicine symptoms and accelerate neurological function recovery in patients with acute cerebral infarction and phlegm stasis obstruction syndrome.

Huatan Tongluo Formula; Acute cerebral infarction; Phlegm stasis obstructing collaterals syndrome